Invention Grant
- Patent Title: Isoxazole analogs as FXR agonists and methods of use thereof
-
Application No.: US16217749Application Date: 2018-12-12
-
Publication No.: US10689391B2Publication Date: 2020-06-23
- Inventor: Yat Sun Or , Jun Ma , Guoqiang Wang , Xuechao Xing , Ruichao Shen , Bin Wang
- Applicant: Enanta Pharmaceuticals, Inc.
- Applicant Address: US MA Watertown
- Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee: Enanta Pharmaceuticals, Inc.
- Current Assignee Address: US MA Watertown
- Agency: Elmore Patent Law Group, P.C.
- Agent Edgar W. Harlan; Carolyn S. Elmore
- Main IPC: C07D491/048
- IPC: C07D491/048 ; C07D493/04 ; C07D487/04 ; C07D417/14
Abstract:
The present invention provides compounds of Formula (I), and pharmaceutically acceptable salts thereof, as well as pharmaceutical compositions comprising these compounds and methods of using these compounds to prevent or treat FXR-mediated or TGR5-mediated diseases or conditions.
Public/Granted literature
- US20190194216A1 ISOXAZOLE ANALOGS AS FXR AGONISTS AND METHODS OF USE THEREOF Public/Granted day:2019-06-27
Information query
